Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study.
Dillen DMM, Vlaar PJ, Vermeer AJE, Paradies V, van Kuijk JP, Vink MA, Oemrawsingh RM, Hofma SH, Magro M, Remkes WS, de Smet BJGL, van Rees JB, Somi S, Halim J, Zimmermann FM, Wijnbergen IF, Tijssen JGP, Tonino PAL, Teeuwen K. Dillen DMM, et al. Among authors: vink ma. Am Heart J. 2023 Dec;266:168-175. doi: 10.1016/j.ahj.2023.09.010. Epub 2023 Oct 6. Am Heart J. 2023. PMID: 37806333 Clinical Trial.
Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study.
Dirksen MT, Vink MA, Suttorp MJ, Tijssen JG, Patterson MS, Slagboom T, Kiemeneij F, Laarman GJ; Paclitaxel-Eluting Stent versus Conventional Stent; in Myocardial Infarction with ST-Segment Elevation (PASSION) investigators. Dirksen MT, et al. Among authors: vink ma. EuroIntervention. 2008 May;4(1):64-70. doi: 10.4244/eijv4i1a12. EuroIntervention. 2008. PMID: 19112781 Clinical Trial.
5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
Vink MA, Dirksen MT, Suttorp MJ, Tijssen JG, van Etten J, Patterson MS, Slagboom T, Kiemeneij F, Laarman GJ. Vink MA, et al. JACC Cardiovasc Interv. 2011 Jan;4(1):24-9. doi: 10.1016/j.jcin.2010.11.003. JACC Cardiovasc Interv. 2011. PMID: 21251625 Free article. Clinical Trial.
Lack of long-term clinical benefit of thrombus aspiration during primary percutaneous coronary intervention with paclitaxel-eluting stents or bare-metal stents: post-hoc analysis of the PASSION-trial.
Vink MA, Dirksen MT, Tijssen JG, Suttorp MJ, Patterson MS, van Geloven N, Ijsselmuiden AJ, Slagboom T, Kiemeneij F, Laarman GJ. Vink MA, et al. Catheter Cardiovasc Interv. 2012 May 1;79(6):870-7. doi: 10.1002/ccd.23226. Epub 2011 Dec 12. Catheter Cardiovasc Interv. 2012. PMID: 21735533 Clinical Trial.
Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The 'wait a day' approach might be safer.
Oosterwerff EF, Fagel ND, Slagboom T, Tijssen JG, Herrman JP, Smits PC, Suttorp MJ, Ronner E, Laarman GJ, Patterson MS, Amoroso G, Vink MA, van der Schaaf RJ, Verheugt FW, Riezebos RK. Oosterwerff EF, et al. Among authors: vink ma. Neth Heart J. 2016 Mar;24(3):173-80. doi: 10.1007/s12471-016-0803-0. Neth Heart J. 2016. PMID: 26860709 Free PMC article.
Coronary angiography after cardiac arrest: Rationale and design of the COACT trial.
Lemkes JS, Janssens GN, Straaten HM, Elbers PW, van der Hoeven NW, Tijssen JG, Otterspoor LC, Voskuil M, van der Heijden JJ, Meuwissen M, Rijpstra TA, Vlachojannis GJ, van der Vleugel RM, Nieman K, Jewbali LS, Bleeker GB, Baak R, Beishuizen B, Stoel MG, van der Harst P, Camaro C, Henriques JP, Vink MA, Gosselink MT, Bosker HA, Crijns HJ, van Royen N; COACT investigators. Lemkes JS, et al. Among authors: vink ma. Am Heart J. 2016 Oct;180:39-45. doi: 10.1016/j.ahj.2016.06.025. Epub 2016 Jul 14. Am Heart J. 2016. PMID: 27659881 Clinical Trial.
Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudy.
Tijssen RYG, van der Schaaf RJ, Kraak RP, Vink MA, Hofma SH, Arkenbout EK, Weevers APJD, Kerkmeijer LSM, Onuma Y, Serruys PW, Beijk MAM, Koch KT, Baan J Jr, Vis MM, Piek JJ, Tijssen JGP, Henriques JPS, de Winter RJ, Wykrzykowska JJ. Tijssen RYG, et al. Among authors: vink ma. Catheter Cardiovasc Interv. 2020 Jan;95(1):89-96. doi: 10.1002/ccd.28193. Epub 2019 Apr 9. Catheter Cardiovasc Interv. 2020. PMID: 30968559 Clinical Trial.
66 results